
- Home
- Companies
- Bertin Technologies
- News
- Exploring Biomarkers for Regorafenib ...

Exploring Biomarkers for Regorafenib Response in Metastatic Colorectal Cancer with the Precellys Evolution
Feb. 4, 2024
Courtesy ofBertin Technologies
Colorectal cancer affects the colon or rectum and is on the rise among young adults. Lifestyle factors like diet and physical inactivity may contribute to its incidence. Early detection through regular screenings is crucial for effective management. Awareness of symptoms and risk factors is essential for timely intervention.
The 4th of February marks the World Cancer Day. In this publication, find out how Bertin Technologies is involved in the detection of carcinogenic cells and how the Precellys Evolution along with the CKMix lysing kit contributed to efficiently homogenizing frozen tissue samples for DNA and RNA extraction.
Stay in the loop!
Select your areas of interest to receive industry updates.